VHL-Mediated Regulation of CHCHD4 and Mitochondrial Function

Area of Science:

• Molecular Biology
• Oncology
• Mitochondrial Biology

Background:

• Dysregulated mitochondrial function is implicated in renal disease and cancer.
• The von Hippel-Lindau tumor suppressor protein (pVHL) is known to regulate mitochondrial biogenesis and function, primarily through its role in degrading hypoxia-inducible factor (HIF)-α.
• In clear cell renal carcinoma, VHL gene inactivation leads to constitutive HIF activation, driving tumor progression and metastasis, with pVHL re-expression suppressing tumor growth and enhancing mitochondrial function.

Purpose of the Study:

• To investigate the mechanisms by which pVHL regulates mitochondrial function in renal carcinoma cells, independent of its canonical HIF regulation.
• To identify specific mitochondrial components and metabolic pathways affected by pVHL re-expression.

Main Methods:

• Re-expression of wild-type pVHL in pVHL-defective renal carcinoma cell lines (786O and RCC10).
• Analysis of mitochondrial protein expression (CHCHD4, NDUFB10, mtCO-2, COX IV) and oxygen consumption rate (OCR).
• Assessment of glucose and glutamine metabolism, mitochondrial morphology, and network dynamics.
• Knockdown of HIF-2α and expression of pVHL mutant proteins to dissect regulatory roles.

Main Results:

• pVHL re-expression elevated CHCHD4, NDUFB10, and COX IV expression, enhancing mitochondrial respiratory chain function.
• Increased OCR and altered glucose/glutamine metabolism were observed following pVHL re-expression.
• Knockdown of HIF-2α mimicked some pVHL-mediated effects on OCR and gene expression.
• pVHL mutants differentially affected mitochondrial phenotype and metabolism, suggesting complex regulatory interactions.

Conclusions:

• pVHL regulates mitochondrial function in renal carcinoma cells through mechanisms distinct from HIF-α degradation.
• pVHL influences mitochondrial protein import (CHCHD4) and respiratory chain complex expression.
• These findings reveal a novel role for pVHL in modulating mitochondrial dynamics and metabolism in the context of renal cell carcinoma.